Protalix BioTherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PLX and other ETFs, options, and stocks.

About PLX

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. 

CEO
Dror Bashan
CEODror Bashan
Employees
213
Employees213
Headquarters
Hackensack, New Jersey
HeadquartersHackensack, New Jersey
Founded
1993
Founded1993
Employees
213
Employees213

PLX Key Statistics

Market cap
227.59M
Market cap227.59M
Price-Earnings ratio
40.72
Price-Earnings ratio40.72
Dividend yield
Dividend yield
Average volume
974.14K
Average volume974.14K
High today
$2.88
High today$2.88
Low today
$2.72
Low today$2.72
Open price
$2.81
Open price$2.81
Volume
705.35K
Volume705.35K
52 Week high
$3.19
52 Week high$3.19
52 Week low
$1.32
52 Week low$1.32

Stock Snapshot

The current Protalix BioTherapeutics(PLX) stock price is $2.85, with a market capitalization of 227.59M. The stock trades at a price-to-earnings (P/E) ratio of 40.72.

On 2026-03-14, Protalix BioTherapeutics(PLX) stock moved within a range of $2.72 to $2.88. With shares now at $2.85, the stock is trading +4.8% above its intraday low and -1.0% below the session's peak.

Trading volume for Protalix BioTherapeutics(PLX) stock has reached 705.35K, versus its average volume of 974.14K.

The stock's 52-week range extends from a low of $1.32 to a high of $3.19.

The stock's 52-week range extends from a low of $1.32 to a high of $3.19.

People also own

Based on the portfolios of people who own PLX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.